Table 1. Univariate and multivariate Cox proportional hazards model predicting survival in ccRCC patients.
Variables | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | ||
Age | 0.017 | 0.160 | |||
>60 vs. ≤60 | 1.497 (1.074–2.085) | 1.404 (0.875–2.253) | |||
Gender | 0.605 | 0.665 | |||
Male vs. female | 0.914 (0.651–1.284) | 1.112 (0.689–1.795) | |||
T stage | 0.000 | 0.111 | |||
T3/T4 vs. T1/T2 | 3.091 (2.215–4.314) | 2.221 (0.831–5.933) | |||
Lymph node metastasis | 0.008 | 0.377 | |||
N1 vs. N0 | 2.853 (1.308–6.225) | 1.459 (0.631–3.377) | |||
Distant metastasis | 0.000 | 0.002 | |||
M1 vs. M0 | 4.827 (3.441–6.769) | 2.589 (1.421–4.717) | |||
Clinical stage | 0.000 | 0.849 | |||
III/IV vs. I/II | 3.815 (2.694–5.403) | 0.900 (0.302–2.680) | |||
Grade | 0.000 | 0.047 | |||
G4/G3 vs. G1/G2 | 2.650 (1.822–3.854) | 1.709 (1.008–2.899) | |||
PTPRO expression | 0.039 | 0.005 | |||
Low vs. high | 1.415 (1.017–1.969) | 1.955 (1.224–3.122) |
ccRCC, clear cell renal cell carcinoma; G, grade; T, tumor; N, node; M, metastasis; HR, hazard ratio; CI, confidence interval.